CYTH — Cyclo Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $23.04m
- $34.29m
- $1.08m
Annual cashflow statement for Cyclo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.53 | -8.94 | -14.3 | -15.5 | -20.1 |
| Depreciation | |||||
| Non-Cash Items | 0.45 | 0.271 | 0.493 | 0.365 | 0.79 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.487 | 0.117 | -1.23 | -0.048 | 3.06 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -6.59 | -8.54 | -15 | -15.1 | -16.2 |
| Capital Expenditures | -0.001 | -0.053 | -0.022 | -0.015 | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.037 | 0.039 | 0.037 | 0.053 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.036 | -0.014 | 0.015 | 0.038 | -0.002 |
| Financing Cash Flow Items | 0.13 | 0 | — | — | 9.35 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.12 | 18.6 | 18.8 | 0.007 | 23.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.566 | 10.1 | 3.77 | -15.1 | 7.7 |